The Effect of Levocarnitine on the Patient with Non-alcoholic Fatty Liver Disease
Not Applicable
Recruiting
- Conditions
- on-Alcoholic Fatty Liver Disease (NAFLD)
- Registration Number
- JPRN-UMIN000009133
- Lead Sponsor
- Kanazawa University Graduate School of Medical Science, Disease Contral and Homeostasis
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
The following patients should be excluded 1. Infected with HBV or HCV 2. Alcohol assumption per day; greater than 20g 3. Complicated with malignant disease including hepatocellular carcinoma 4. Complicated with obvious hepatic encephalopathy 5. Complicated with active infectious disease 6. Complicated with Critical complications 7. Nursing and Pregnant woman 8. Taking contraindicating medicines with Levocarnitine 9. Taking pioglitazone and metformin 10.the other patients who the doctors in charge consider should not enter this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method